Processes for preparing tucatinib polymorphs
AssigneeMacfarlan Smith Limited
InventorsThierry BONNAUD, Adam Ross PATTERSON, Zoe PRENTICE, Mark Alexander WRIGHT
Life of this patent
Estimating the term…
Abstract
The present invention is directed to processes for making various polymorphs of tucatinib, designated herein as Form I, Form II, and Form III of tucatinib. These forms can then be used to prepare pharmaceutical formations containing tucatinib. Tucatinib is a tyrosine kinase inhibitor that is indicated for the treatment of breast cancer.
Claims19
A process for the preparation of Form I of tucatinib comprising:
- a) combining tucatinib and DMSO and heating to about 50-70° C. to form a solution;
- and
- b) adding water to the solution to yield Form I of tucatinib as a precipitate, wherein about 2-4 volumes of DMSO (mL) is used per weight (g) of tucatinib.
A process for the preparation of Form II of tucatinib comprising:
- a) suspending tucatinib in a solvent mixture of DMSO and water;
- b) heating the suspension to about 70-90° C. at about 0.5° C./minute;
- and
- c) cooling the suspension to about 5-15° C. at about 0.5° C./minute to yield Form II of tucatinib, wherein about 16-20 volumes of solvent mixture (mL) is used per weight (g) of tucatinib.
A process for the preparation of Form II of tucatinib comprising:
- a) combining tucatinib and DMSO at about 50-70° C. to form a solution;
- b) cooling the solution to a first lower temperature;
- c) optionally adding water to the solution, wherein step b) may be performed before or after step c);
- d) adding seeds of Form II of tucatinib to the solution to form a suspension;
- e) adding additional water to the suspension to yield Form II of tucatinib, wherein the suspension is optionally cooled to a second lower temperature before or after the adding additional water and wherein about 3-6 volumes of DMSO (mL) are used per weight (g) of tucatinib.
The process of claim 17, wherein the second lower temperature is about 20-30° C.
A process for the preparation of Form II of tucatinib comprising:
- a) combining tucatinib and DMSO at about 50-70° C. to form a solution;
- b) cooling the solution;
- c) preparing a suspension seeds of Form II of tucatinib in water;
- and
- d) adding the DMSO/tucatinib solution to the seed suspension to yield Form II of tucatinib as a precipitate, wherein about 3-6 volumes of DMSO (mL) is used per weight (g) of tucatinib.
A process for the preparation of Form III of tucatinib comprising:
- a) combining tucatinib and a solvent mixture of THF and water, then heating the mixture to about 50-70° C. to form a solution;
- b) cooling the solution to about 35-45° C.;
- and
- c) evaporating a portion of the solution to yield Form III of tucatinib as a precipitate, wherein about 15-20 volumes (mL) of the solvent mixture is used per weight (g) of tucatinib and wherein the volume ratio of THF to water in the solvent mixture is about 9:1.
Dependencies are inferred from the claim text.